Source: StreetInsider

Press Release: Sarepta : Sarepta Therapeutics to Present at Credit Suisse 27th Annual Healthcare Conference

Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a leader in precision genetic medicine for rare diseases, today announced that management will present at the Credit Suisse 27th Annual Healthcare Conference on Wednesday, November 14, 2018 at 10:55 a.m. Mountain Time / 12:55 p.m.

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Based on data from Sarepta Therapeutics's latest SEC filings

Annual Revenue

Based on data from Sarepta Therapeutics's latest SEC filings

Employees

Douglas S. Ingram's photo - President & CEO of Sarepta Therapeutics

President & CEO

Douglas S. Ingram

CEO Approval Rating

89/100

Sarepta develops and commercializes ribonucleic acid targeted therapeutics for the treatment of neuromuscular diseases.

S...
Read more